Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient

Keyphrases

• Autoimmune 100%
• Pediatric Heart Transplant 100%
• Heart Transplant Recipients 100%
• Bowel Dysfunction 100%
• Basiliximab 100%
• Remission 40%
• T Cell Activation 20%
• Esophagus 20%
• Inflammatory Process 20%
• Disease Process 20%
• Young Female 20%
• Treatment Methods 20%
• Terminal Ileum 20%
• Long-term Complications 20%
• Endoscopic Diagnosis 20%
• Sirolimus 20%
• Maintenance Immunosuppression 20%
• Fever 20%
• Steroid-induced 20%
• Immune Assay 20%
• Tracheostomy 20%
• Tacrolimus 20%
• Immune Therapy 20%
• Activated T Cells 20%
• Heart Transplant 20%
• Methylprednisolone 20%
• Right Colon 20%
• Bowel Resection 20%
• Left Colon 20%
• Airway Inflammation 20%
• Sustained Remission 20%
• Successful Weaning 20%
• Mycophenolate 20%
• Bowel Rest 20%
• Esophageal Ulcer 20%
• Bloody Stool 20%
• Traditional Treatment 20%
• Autoimmune Dysregulation 20%
• Elevated ESR 20%
• Ulcerative Disease 20%

Medicine and Dentistry

• Pediatrics 100%
• Heart Graft 100%
• Enteropathy 100%
• Basiliximab 100%
• Heart Transplantation 40%
• Serositis 20%
• T Cell Activation 20%
• Immunosuppressive Treatment 20%
• Transplantation 20%
• Disease 20%
• Immunotherapy 20%
• Esophagus 20%
• Disease Process 20%
• T Cell 20%
• Terminal Ileum 20%
• Colon 20%
• Venous Ulcer 20%
• Tracheostomy 20%
• Tacrolimus 20%
• Methylprednisolone 20%
• Rapamycin 20%
• Bowel Resection 20%
• Immunity 20%
• Rectal Bleeding 20%
• Mycophenolic Acid 20%
• Respiratory Tract Inflammation 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Enteropathy 100%
• Basiliximab 100%
• Remission 60%
• Disease 40%
• Inflammation 20%
• Immunotherapy 20%
• Mycophenolic Acid 20%
• Ulcer 20%
• Rapamycin 20%
• Ileum 20%
• Methylprednisolone 20%
• Tacrolimus 20%
• Respiratory Tract Inflammation 20%
• Rectum Hemorrhage 20%